发明名称 CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS
摘要 <P>PROBLEM TO BE SOLVED: To prepare sustained or controlled release dosage form composed of a drug topically active in the gastrointestinal tract. <P>SOLUTION: Composition include a three-component matrix structure comprising: (a) a lipophilic matrix in which an active ingredient is partially contained, provided that the lipophilic matrix comprises a lipophilic compound having a melting point within the range of 40-90&deg;C; (b) an amphiphilic matrix; and (c) an outer hydrophilic matrix comprising a hydrogel-forming compound wherein the lipophilic matrix and the amphiphilic matrix are dispersed. <P>COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011102311(A) 申请公布日期 2011.05.26
申请号 JP20110000092 申请日期 2011.01.04
申请人 COSMO TECHNOLOGIES LTD 发明人 VILLA ROBERTO;PEDRANI MASSIMO;AJANI MAURO;FOSSATI LORENZO
分类号 A61K31/58;A61K9/16;A61K9/20;A61K9/22;A61K9/48;A61K31/14;A61K31/155;A61K31/18;A61K31/192;A61K31/195;A61K31/196;A61K31/198;A61K31/221;A61K31/34;A61K31/4402;A61K31/4425;A61K31/551;A61K31/606;A61K47/08;A61K47/10;A61K47/12;A61K47/14;A61K47/16;A61K47/18;A61K47/24;A61K47/26;A61K47/28;A61K47/30;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/40;A61K47/44;A61P1/00;A61P1/04;A61P3/10;A61P9/00;A61P9/12;A61P11/08;A61P11/14;A61P25/00;A61P25/04;A61P25/16;A61P25/18;A61P25/22;A61P29/00;A61P31/04;A61P43/00 主分类号 A61K31/58
代理机构 代理人
主权项
地址